MMBEX Performance — MassMutual Select T. Rowe Price Bond Asset Fund, Class I
Data updated: 2025-08-25
MMBEX returned +6.64% over one year to Jun 2025. Annualised returns are +3.20% over 3 years and +0.24% over 5 years. The fund trailed its Global Long-Term Core Bond category average: $100 invested three years ago grew to $110, against $112 for the category, and to $107 over one year, against $107. Volatility over the past three years was 6.55% a year. In the 12 months to Jun 2025 the fund lost a net $356.3M, and assets reached $191.61M.
MMBEX Growth of $100
What $100 invested in MassMutual Select T. Rowe Price Bond Asset Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Long-Term Core Bond category average over the same months.
| Period | MMBEX | Category average |
|---|---|---|
| 1 year (Jul 2024 – Jun 2025) | $107 | $107 |
| 3 years (Jul 2022 – Jun 2025) | $110 | $112 |
| 5 years (Jul 2020 – Jun 2025) | $101 | $103 |
| Since data start (Jul 2019 – Jun 2025) | $106 | $106 |
MMBEX Trailing Returns
Total returns to Jun 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +6.64% |
| 3 years (annualised) | +3.20% |
| 5 years (annualised) | +0.24% |
MMBEX Annual Returns
Calendar-year total returns of MassMutual Select T. Rowe Price Bond Asset Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Jun) | +3.90% |
| 2024 | +2.41% |
| 2023 | +6.60% |
| 2022 | −13.26% |
| 2021 | −0.43% |
| 2020 | +5.74% |
| 2019 (Jul–Dec) | +2.48% |
MMBEX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | −0.1% | +1.8% | +0.7% | +0.6% | −0.5% | +1.4% | — | — | — | — | — | — |
| 2024 | +0.8% | −1.1% | −0.2% | +0.5% | +1.6% | −1.8% | +1.1% | +1.4% | +2.1% | −1.3% | +1.1% | −1.8% |
| 2023 | +2.2% | −1.7% | +2.5% | −0.2% | −0.7% | +0.4% | −1.9% | −0.5% | +0.1% | +3.6% | +4.2% | −1.3% |
| 2022 | −2.1% | −1.3% | −1.7% | −2.1% | −0.1% | −3.6% | −4.5% | −2.9% | +2.9% | −0.7% | +3.4% | −1.0% |
| 2021 | −0.6% | −1.4% | −0.5% | +0.7% | +0.3% | +0.7% | −0.9% | 0.0% | +1.1% | −0.1% | +0.4% | −0.1% |
| 2020 | −5.9% | +1.0% | +1.7% | +1.6% | +1.4% | +2.9% | −0.1% | −0.3% | +1.8% | +0.6% | +1.3% | −0.1% |
| 2019 | — | — | — | — | — | — | −0.6% | +2.3% | +0.4% | +0.1% | −0.1% | +0.3% |
MMBEX Risk
Risk measures from monthly returns over Jul 2022 – Jun 2025.
- 3-year volatility (annualised): 6.55%
- 3-year Sharpe ratio: -0.20 (vs 4.5% risk-free rate)
- Best month: +4.18% (Nov 2023)
- Worst month: −4.54% (Jul 2022)
MMBEX Fund Flows
Monthly money in and out of MassMutual Select T. Rowe Price Bond Asset Fund, from SEC Form N-PORT.
- 12-month net flow: −$356.3M
- 12-month gross sales (incl. reinvestments): $121.6M
- Sales ÷ redemptions: 0.25×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2025 | $3.2M | $4.6M | −$1.4M |
| May 2025 | $5.4M | $15.1M | −$9.6M |
| Apr 2025 | $1.1M | $15.2M | −$14.1M |
| Mar 2025 | $21.1M | $305.2M | −$284.1M |
| Feb 2025 | $1.1M | $6.4M | −$5.3M |
| Jan 2025 | $1.2M | $12.1M | −$10.9M |
| Dec 2024 | $17.2M | $9.2M | $7.9M |
| Nov 2024 | $5.5M | $16.9M | −$11.4M |
| Oct 2024 | $30.4M | $11.3M | $19.1M |
| Sep 2024 | $14.4M | $37.3M | −$22.9M |
| Aug 2024 | $12.2M | $28.2M | −$15.9M |
| Jul 2024 | $8.9M | $16.5M | −$7.6M |
MMBEX Assets Under Management
Net assets of MassMutual Select T. Rowe Price Bond Asset Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-06-30 | $191.61M |
| 2025-03-31 | $212.88M |
| 2024-12-31 | $508.73M |
| 2024-09-30 | $524.38M |
| 2024-06-30 | $546.38M |
| 2024-03-31 | $634.18M |
| 2023-12-31 | $623.10M |
| 2023-09-30 | $593.58M |
| 2023-06-30 | $584.79M |
| 2023-03-31 | $563.04M |
| 2022-12-31 | $554.28M |
| 2022-09-30 | $558.49M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.